IGF1 and neoplasm: In another in vivo study, it was observed that C57B6 mice fed with HED and CRD and treated daily with the anti-diabetic agent metformin displayed a significant reduction in tumor volume along with a reduction in circulating levels of IGF-1, IL-6, and leptin in both plasma and ascetic fluid, similar to the CRD mice [194].